ARKG Holdings of Recursion Pharmaceuticals (RXRX) - Updated Daily
Join Premium Plan
Key Statistics
Statistics
Institutional Ownership Trends
News That Matters
| 🕵🏼Found In | 🏷Last Price |
|---|---|
| ARKG | $6.91 |
| ⚖️Weighting | 🧢Market Cap |
| 0.53% | $1.17b |
| 🏋🏿♂️Weight Rank In ARKG | 🧮Price to Sales |
| 41 | 112.98 |
| 🏋️♀️Weight Rank Across All Funds | 🌏Country |
| 109 | 🇺🇸United States |
| 💳ARK Estimated Cost Average | 🎫ARK Ownership Percent |
| $26.64 | 1.76% |
| Description | |
|---|---|
| Recursion is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Central to its mission is the Recursion Operating System, or Recursion OS, that combines an advanced infrastructure layer to generate what Recursion believes is one of the world's largest and fastest-growing proprietary biological and chemical datasets and the Recursion Map, a suite of custom software, algorithms, and machine learning tools that the company uses to explore foundational biology unconstrained by human bias and navigate to new biological insights which may accelerate its programs. biotechnology company scaling more like a technology company. | |
| Website | |
| www.recursionpharma.com |
Research Notes and Commentary for RXRX
No Research Notes Found for RXRX